Cargando…
Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells
Human peritoneal mesothelial cells (MC) play an important role in inflammatory processes of the peritoneal cavity by producing various cytokines and chemokines, such as monocyte chemoattractant protein-1 (MCP-1). The present study was designed to assess the effect of the peroxisome proliferator-acti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306974/ https://www.ncbi.nlm.nih.gov/pubmed/22496599 http://dx.doi.org/10.1155/2012/217696 |
_version_ | 1782227266040758272 |
---|---|
author | Sauter, Matthias Kastenmüller, Kathrin Belling, Franziska Wörnle, Markus Ladurner, Roland Mussack, Thomas Sitter, Thomas |
author_facet | Sauter, Matthias Kastenmüller, Kathrin Belling, Franziska Wörnle, Markus Ladurner, Roland Mussack, Thomas Sitter, Thomas |
author_sort | Sauter, Matthias |
collection | PubMed |
description | Human peritoneal mesothelial cells (MC) play an important role in inflammatory processes of the peritoneal cavity by producing various cytokines and chemokines, such as monocyte chemoattractant protein-1 (MCP-1). The present study was designed to assess the effect of the peroxisome proliferator-activated receptor-gamma- (PPARγ-) activator rosiglitazone on the mesothelial MCP-1 expression and release. Primary cultures of MC were obtained from omental tissue. MCP-1 antigen concentrations were measured in the cell supernatant by ELISA and MCP-1 mRNA levels by real-time polymerase chain reaction. The presence of PPARγ on MC was assayed in a Western Blot analysis. MC constitutively express PPARγ. Activation of this receptor via rosiglitazone (0,1–10 μmol/L) resulted in significantly reduced amounts of mesothelial MCP-1 release as well as MCP-1 mRNA. The use of the PPARγ inhibitor GW-9662 could completely prevent the rosiglitazone effects. Rosiglitazone was also effective in reducing TNFα-induced enhanced secretion of MCP-1. Our findings indicate that glitazones are effective in reducing constitutive and TNFα-stimulated mesothelial MCP-1 mRNA expression and release. |
format | Online Article Text |
id | pubmed-3306974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33069742012-04-11 Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells Sauter, Matthias Kastenmüller, Kathrin Belling, Franziska Wörnle, Markus Ladurner, Roland Mussack, Thomas Sitter, Thomas Mediators Inflamm Research Article Human peritoneal mesothelial cells (MC) play an important role in inflammatory processes of the peritoneal cavity by producing various cytokines and chemokines, such as monocyte chemoattractant protein-1 (MCP-1). The present study was designed to assess the effect of the peroxisome proliferator-activated receptor-gamma- (PPARγ-) activator rosiglitazone on the mesothelial MCP-1 expression and release. Primary cultures of MC were obtained from omental tissue. MCP-1 antigen concentrations were measured in the cell supernatant by ELISA and MCP-1 mRNA levels by real-time polymerase chain reaction. The presence of PPARγ on MC was assayed in a Western Blot analysis. MC constitutively express PPARγ. Activation of this receptor via rosiglitazone (0,1–10 μmol/L) resulted in significantly reduced amounts of mesothelial MCP-1 release as well as MCP-1 mRNA. The use of the PPARγ inhibitor GW-9662 could completely prevent the rosiglitazone effects. Rosiglitazone was also effective in reducing TNFα-induced enhanced secretion of MCP-1. Our findings indicate that glitazones are effective in reducing constitutive and TNFα-stimulated mesothelial MCP-1 mRNA expression and release. Hindawi Publishing Corporation 2012 2012-02-07 /pmc/articles/PMC3306974/ /pubmed/22496599 http://dx.doi.org/10.1155/2012/217696 Text en Copyright © 2012 Matthias Sauter et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sauter, Matthias Kastenmüller, Kathrin Belling, Franziska Wörnle, Markus Ladurner, Roland Mussack, Thomas Sitter, Thomas Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells |
title | Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells |
title_full | Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells |
title_fullStr | Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells |
title_full_unstemmed | Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells |
title_short | Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells |
title_sort | activation of peroxisome proliferator-activated receptor-gamma by glitazones reduces the expression and release of monocyte chemoattractant protein-1 in human mesothelial cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306974/ https://www.ncbi.nlm.nih.gov/pubmed/22496599 http://dx.doi.org/10.1155/2012/217696 |
work_keys_str_mv | AT sautermatthias activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells AT kastenmullerkathrin activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells AT bellingfranziska activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells AT wornlemarkus activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells AT ladurnerroland activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells AT mussackthomas activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells AT sitterthomas activationofperoxisomeproliferatoractivatedreceptorgammabyglitazonesreducestheexpressionandreleaseofmonocytechemoattractantprotein1inhumanmesothelialcells |